Category Archives: Op-Ed

The Technologies Set to Transform Healthcare

By G. Steven Burrill, CEO, Burrill & Company. The promise of precision medicine is beginning to bear fruit as deadly diseases are made treatable, doctors use genetic information to guide treatment decisions, and the convergence of information, communications, and biological technology reinvents the practice of medicine. The arrival of this new age of medicine has […]
Also posted in Biotech, Global, Guest Blog, healthcare, Technology | Tagged , , , | Leave a comment

Value-Based Assessment in the UK: The Patient View

By Leela Barham. Patients are influential in the UK when it comes to access to medicines: their individual stories are highlighted in the media and the groups that represent them are credited with major policies. For example, the Rarer Cancer Foundation (RCF) has been credited in large part with the introduction of the Cancer Drugs […]
Also posted in Europe, Guest Blog, pricing | Tagged , , , , , , | Leave a comment

European Pharma Policy Reaches "New Level of Timidity"

By Peter O’ Donnell, Applied Clinical Trials. The European Union has managed to snatch defeat from the jaws of opportunity once more! A long-heralded document portentously entitled “Pharmaceutical industry: a strategic sector for the European economy,” and supposedly initiating a new start in long-term thinking about boosting the drug industry, squeezes the thinnest and weakest […]
Also posted in Europe, Guest Blog, Regulatory | Tagged , , | Leave a comment

Show Me the Money: First New PPRS Payments in UK

By Leela Barham. The Pharmaceutical Price Regulation Scheme (PPRS) is a long-standing scheme where the pharmaceutical industry, represented by the Association of the British Pharmaceutical Industry (ABPI), negotiates with the Department of Health (DH) to agree how to indirectly manage the price of branded medicines. Its latest incarnation includes a brand new feature. Instead of […]
Also posted in Europe, Global, Guest Blog, pricing | Tagged , , , , | Leave a comment

Mastering the Language of Payers

By Sydney Rubin. The first rule of effective communications — whether speaking to a beloved offspring or an important customer — is to know your audience. We must understanding what motivates the listener, what they care about, what language will most likely persuade. Don’t expect an argument on the importance of retirement savings to convince […]
Also posted in Guest Blog, Marketing | Tagged , , , | Leave a comment
  • Categories

  • Meta